The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days

Background: Never before have clinical trials drawn as much public attention as those testing interventions for COVID-19. We aimed to describe the worldwide COVID-19 clinical research response and its evolution over the first 100 days of the pandemic. Methods: Descriptive analysis of planned, ongoin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:F1000Res
Autors principals: Janiaud, Perrine, Axfors, Cathrine, van't Hooft, Janneke, Saccilotto, Ramon, Agarwal, Arnav, Appenzeller-Herzog, Christian, Contopoulos-Ioannidis, Despina G., Danchev, Valentin, Dirnagl, Ulrich, Ewald, Hannah, Gartlehner, Gerald, Goodman, Steven N., Haber, Noah A., Ioannidis, Angeliki Diotima, Ioannidis, John P. A., Lythgoe, Mark P., Ma, Wenyan, Macleod, Malcolm, Malički, Mario, Meerpohl, Joerg J., Min, Yan, Moher, David, Nagavci, Blin, Naudet, Florian, Pauli-Magnus, Christiane, O'Sullivan, Jack W., Riedel, Nico, Roth, Jan A., Sauermann, Mandy, Schandelmaier, Stefan, Schmitt, Andreas M., Speich, Benjamin, Williamson, Paula R., Hemkens, Lars G.
Format: Artigo
Idioma:Inglês
Publicat: F1000 Research Limited 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7539080/
https://ncbi.nlm.nih.gov/pubmed/33082937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.26707.2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars